Comprehensive Biologics LLC, Advancing Healthcare Through Regenerative Medicine.
BiologicalMatrix-50, BiologicalMatrix Pro, and BiologicalAmnio are minimally manipulated human tissue allografts that possess a robust extracellular matrix, including Collagen and High Molecular Weight Hyaluronic Acid. They are, therefore, excellent choices when extra cushioning, structural support, and viscosity are needed. In addition to advancing the science of Regenerative Medicine, Comprehensive Biologics provides industry-leading products, business solutions, and education for Clinicians and patients alike. Comprehensive Biologics…
Comprehensive Biologics’ human umbilical cord and placental derived products’ proprietary tissue manufacturing processes do not alter the tissue's original relevant characteristics, resulting in a pure, homologous product. As Comprehensive Biologics strives to further the science of Regenerative Medicine, quality and safety remain paramount. While maintaining FULL oversight of the production of Comprehensive Biologics’ innovative products, our dedicated Quality Assurance team is committed to complying with the highest regulatory standards. We ensure all of our products will meet or exceed established specifications and undergo independent sterility testing per standards set forth by the American Association of Tissue Banks (AATB) and FDA requirements. Our products are (HCT/P) compliant under Section 361 of the Public Health Service Act according to 21 CFR Part 1271.10. They are regulated as a human cell and tissue product and are intended for homologous use.